BrainTrip

**BrainTrip**, a promising **startup** founded in **2019** and headquartered in **Malta**, is making significant strides in the **healthcare** industry by focusing on cognitive health and longevity. With their innovative approach, they are bringing attention to an area often overshadowed in the wellness industry: brain health.

The company’s cutting-edge product, **CogniScore**, combines advanced **AI** technologies with **EEG** methods to provide an objective and non-invasive insight into brain function. This assists in the early detection of cognitive decline and potential dementia, allowing healthcare providers to guide their patients effectively towards optimal cognitive vitality. **BrainTrip**’s scientifically validated algorithm enables individuals to take proactive steps for preserving brain health, aiming to help them live longer and healthier lives.

Despite being relatively young, **BrainTrip** garnered attention and received a **Non Equity Assistance investment** on **01 March 2020** from **Fast Track Malmo**. This backing highlights their potential in revolutionizing the way cognitive health is approached, rendering **BrainTrip** a viable consideration for further investment opportunities within the health tech space.